ALPS Advisors »

Aeglea Biotherapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 64k 32.76

More positions owned by ALPS Advisors

Western Midstream Partners L Com Unit Lp Int (WES)
Energy Transfer Com Ut Ltd Ptn (ET)
Enterprise Products Partners (EPD)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Usa Compression Partners Com Unit Ltdpar (USAC)
Genesis Energy Unit Ltd Partn (GEL)
Cameco Corporation (CCJ)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Global Partners Com Units (GLP)
Uranium Energy (UEC)
Delek Logistics Partners Com Unt Rp Int (DKL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for ALPS Advisors

Top funds holding Aeglea Biotherapeutics

FMR
Vanguard Group
Fairmount Funds Management
BlackRock
VR Adviser
Rtw Investments
Tang Capital Management
Capital Research and Management Company - Division 3
State Street Corporation
Driehaus Capital Management
Commodore Capital
Geode Capital Management
Wellington Management Company
Braidwell
Paradigm Biocapital Advisors

View all funds holding Aeglea Biotherapeutics